Sarasin & Partners LLP Edwards Lifesciences Corp Transaction History

Sarasin & Partners LLP

$10.6 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$84.3 - $94.31 $261,667 - $292,738	3,104 Added 1.43%	219,490 $20.3 Million
Q1 2024 Apr 12, 2024	SELL	$72.54 - $95.56 $1.15 Million - $1.51 Million	-15,830 Reduced 6.82%	216,386 $20.7 Million
Q4 2023 Jan 09, 2024	SELL	$61.71 - $77.76 $2.47 Million - $3.11 Million	-39,987 Reduced 14.69%	232,216 $17.7 Million
Q3 2023 Oct 05, 2023	BUY	$69.28 - $93.38 $244,212 - $329,164	3,525 Added 1.31%	272,203 $18.9 Million
Q2 2023 Jul 10, 2023	BUY	$81.41 - $94.33 $1.05 Million - $1.22 Million	12,950 Added 5.06%	268,678 $25.3 Million
Q1 2023 May 05, 2023	BUY	$74.26 - $84.51 $88,592 - $100,820	1,193 Added 0.47%	255,728 $21.2 Million
Q1 2023 Apr 27, 2023	SELL	$74.26 - $84.51 $99,359 - $113,074	-1,338 Reduced 0.52%	254,535 $21.1 Million
Q4 2022 Jan 30, 2023	BUY	$68.3 - $87.44 $191,171 - $244,744	2,799 Added 1.11%	255,873 $19.1 Million
Q3 2022 Oct 18, 2022	SELL	$82.37 - $107.29 $37,560 - $48,924	-456 Reduced 0.18%	253,074 $20.9 Million
Q2 2022 Jul 13, 2022	BUY	$86.5 - $128.27 $21.9 Million - $32.5 Million	253,530 New	253,530 $24.1 Million
Q1 2022 Apr 11, 2022	SELL	$101.96 - $128.34 $26 Million - $32.7 Million	-254,535 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$83.84 - $104.76 $4.39 Million - $5.49 Million	52,386 Added 25.91%	254,535 $26.4 Million
Q4 2020 Jan 19, 2021	BUY	$71.69 - $91.23 $2.77 Million - $3.53 Million	38,676 Added 23.66%	202,149 $18.4 Million
Q3 2020 Nov 09, 2020	BUY	$67.19 - $87.44 $2.11 Million - $2.75 Million	31,473 Added 23.84%	163,473 $13 Million
Q2 2020 Jul 17, 2020	BUY	$57.54 - $76.95 $7.6 Million - $10.2 Million	132,000 New	132,000 $9.12 Million
Q1 2020 Apr 30, 2020	SELL	$52.41 - $81.0 $1.67 Million - $2.59 Million	-31,923 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$71.7 - $82.09 $6,237 - $7,141	-87 Reduced 0.27%	31,923 $7.45 Million
Q3 2019 Nov 08, 2019	BUY	$61.55 - $75.43 $623,809 - $764,483	10,135 Added 46.33%	32,010 $7.04 Million
Q2 2019 Jul 18, 2019	SELL	$55.74 - $64.41 $14,213 - $16,424	-255 Reduced 1.15%	21,875 $4.04 Million
Q3 2018 Nov 09, 2018	BUY	$45.7 - $58.03 $1.01 Million - $1.28 Million	22,130 New	22,130 $3.85 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarasin & Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Sarasin & Partners LLP with notifications on news.

Account